BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36440916)

  • 1. Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis.
    Palterer B; Vitiello G; Del Carria M; D'Onofrio B; Martinez-Prat L; Mahler M; Cammelli D; Parronchi P
    Rheumatology (Oxford); 2023 Jul; 62(7):2410-2417. PubMed ID: 36440916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans.
    Navarro-Millán I; Darrah E; Westfall AO; Mikuls TR; Reynolds RJ; Danila MI; Curtis JR; ; Rosen A; Bridges SL
    Arthritis Res Ther; 2016 Oct; 18(1):241. PubMed ID: 27770831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.
    Giles JT; Darrah E; Danoff S; Johnson C; Andrade F; Rosen A; Bathon JM
    PLoS One; 2014; 9(6):e98794. PubMed ID: 24901704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival.
    Wilson TM; Solomon JJ; Humphries SM; Swigris JJ; Ahmed F; Wang H; Darrah E; Demoruelle MK
    Am J Med Sci; 2023 Jun; 365(6):480-487. PubMed ID: 36918112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
    Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
    Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
    Front Immunol; 2018; 9():2696. PubMed ID: 30515171
    [No Abstract]   [Full Text] [Related]  

  • 7. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
    Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
    Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Factors in PAD2 (
    Nava-Quiroz KJ; Rojas-Serrano J; Pérez-Rubio G; Buendia-Roldan I; Mejía M; Fernández-López JC; Rodríguez-Henríquez P; Ayala-Alcantar N; Ramos-Martínez E; López-Flores LA; Del Ángel-Pablo AD; Falfán-Valencia R
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis.
    Cappelli LC; Konig MF; Gelber AC; Bingham CO; Darrah E
    Arthritis Res Ther; 2018 Mar; 20(1):59. PubMed ID: 29566742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis.
    Seaman A; Darrah E; Infantino M; Meacci F; Manfredi M; Benucci M; Mahler M
    Autoimmun Rev; 2016 Jul; 15(7):776-80. PubMed ID: 26997641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis.
    Zhang G; Xu J; Du D; Liu Y; Dai L; Zhao Y
    Rheumatology (Oxford); 2024 Apr; 63(4):914-924. PubMed ID: 37824204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
    Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
    Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Protein-Arginine Deiminase 4 IgG and IgA Delineate Severe Rheumatoid Arthritis.
    Martinez-Prat L; Martinez-Taboada V; Santos C; Lopez-Hoyos M; Mahler M
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
    Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
    Lamacchia C; Courvoisier DS; Jarlborg M; Bas S; Roux-Lombard P; Möller B; Ciurea A; Finckh A; Bentow C; Martinez-Prat L; Mahler M; Gabay C; Nissen MJ;
    Rheumatology (Oxford); 2021 Oct; 60(10):4598-4608. PubMed ID: 33502443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
    Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
    Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies,
    Guderud K; Mæhlen MT; Nordang GBN; Viken MK; Andreassen BK; Molberg Ø; Flåm ST; Lie BA
    J Rheumatol; 2018 Aug; 45(9):1211-1219. PubMed ID: 29858238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
    Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
    Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
    Pollmann S; Stensland M; Halvorsen EH; Sollid LM; Kvien TK; Fleckenstein B; Molberg O
    Rheumatol Int; 2012 May; 32(5):1271-6. PubMed ID: 21267570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
    Shi J; Darrah E; Sims GP; Mustelin T; Sampson K; Konig MF; Bingham CO; Rosen A; Andrade F
    Ann Rheum Dis; 2018 Jan; 77(1):141-148. PubMed ID: 29070531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.